NewcelX Signs Binding Term Sheet to Divest Mazindol Portfolio
The proposed divestiture provides for upfront cash, equity ownership and up to $55 million in potential milestone payments.
The proposed divestiture provides for upfront cash, equity ownership and up to $55 million in potential milestone payments.